Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

BACKGROUND: Pharmacological inhibitors of vascular endothelial growth factor (VEGF) receptors, like vatalanib, have been tested in randomised trials (CONFIRM (Colorectal Oral Novel therapy For the Inhibition of Angiogenesis and Retarding of Metastases) 1 and 2) in colorectal cancer showing activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Giatromanolaki, A, Koukourakis, M I, Sivridis, E, Gatter, K C, Trarbach, T, Folprecht, G, Shi, M M, Lebwohl, D, Jalava, T, Laurent, D, Meinhardt, G, Harris, A L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461163/
https://www.ncbi.nlm.nih.gov/pubmed/22910317
http://dx.doi.org/10.1038/bjc.2012.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461163/
https://www.ncbi.nlm.nih.gov/pubmed/22910317
http://dx.doi.org/10.1038/bjc.2012.369

Ejemplares similares